Latest kidney cancer Stories
- Two research groups report importance of beta III-tubulin in pancreatic and kidney cancer SYDNEY, Jan.
Research Led By NYU Langone Medical Center Shows Greater Experience Utilizing Robotic Surgery Leads to Better Use for Partial Nephrectomies NEW YORK, Dec.
Launch of Novel Immune Checkpoint Inhibitors Will Fuel Market Growth and Will Dramatically Enhance RCC Treatment Algorithm, According to Findings from Decision Resources Group BURLINGTON, Mass.,
WHIPPANY, N.J., Sept. 24, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
New technology can eliminate or shorten hospital stays and reduce complications for thousands of kidney cancer patients LOS ANGELES, Sept.
MarketOptimizer.org adds “EpiCast Report Renal Cell Carcinoma - Epidemiology Forecast to 2023” to its store.
TUEBINGEN, Germany, July 16, 2014 /PRNewswire/ -- Funds will be used to complete phase 3 study with IMA901 and to invest in the expansion of immatics' Human Immunopeptidome
A genomic analysis of clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, from 72 patients has uncovered 31 genes that are key to development, growth and spread of the cancer
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer.
CAMBRIDGE, Mass., June 16, 2014 /PRNewswire/ -- Boston Biomedical, a company focused on the research and development of novel cancer therapeutics targeting cancer stem cells (CSC), today provided